Landmark CRISPR Breakthrough Makes Us Ask: ‘How Realistic Are Designer Babies?’ – Nerdist
Nerdist |
Landmark CRISPR Breakthrough Makes Us Ask: ‘How Realistic Are Designer Babies?’
Nerdist CRISPR, a remarkably effective biological tool for genetic engineering, recently allowed scientists to remove a malfunctioning gene from a human embryo in a landmark procedure. This success subsequently implies all sorts of future possibilities for … |
New Haven Register |
Rare leukemia targeted by modifying patients’ immune cells
New Haven Register Turning the T cells into CAR–T cells helps by targeting the CD19 marker on the B cells. “CD19 happens to be a pretty good target for cancer technology because it’s only on B cells,” Gore said. “These new CAR–T cells latch onto the leukemia cells.”. |
St. Cloud Times |
Stem cell ‘research’ rankles U of M bioethicist
St. Cloud Times Listed on a government website, they present the opportunity to participate in clinical trials to test the potential of one of the most promising tools in medicine — the body’s own stem cells. It’s an attractive pitch for many patients, even though … Lung fibrosis? Stem cell therapy holds promise – The HinduThe Hindu China Regenerative’s Stem Cell Research Sparks Hope – BloombergBloomberg Asia-Pacific Stem Cell Market Trends and Forecast Report 2017-2022.People Exclusive Digital Journal –WhaTech all 11 news articles » |
Gears Of Biz |
Scientists Successfully Use CRISPR-Edited Skin Grafts To Treat Type-2 Diabetes And Obesity
Gears Of Biz In order to prove this, the team used CRISPR to engineer mouse skin cell grafts that would regulate blood-glucose hormones when applied to diabetic mice with healthy immune systems. The patch carried a mutated gene that extends GLP-1’s half-life and … |
Telegraph.co.uk |
Leading US biotech Bluebird eyes UK launch for pioneering gene therapies
Telegraph.co.uk One of America’s leading biotechs, Bluebird Bio, is in talks with UK medicine regulators about a potential launch of its pioneering range of gene therapies for rare diseases. Bluebird has a market value of over $4bn (£3bn) on New York’s Nasdaq stock … |
Singularity Hub |
Breakthrough Stem Cell Study Offers New Clues to Reversing Aging
Singularity Hub However, when the team transplanted these stem cells from young animals into a middle-aged one, they slowed aging. The recipient mice were smarter, more sociable and had better muscle function. And—get this—they also lived 10 to 15 percent longer … |